CAS: 1346753-05-6 - 9H-Xanthene-2-acetic acid, α-methyl-9-oxo-, compd. with 2,3,4,6,7,8,9,10-octahydropyrimido[1,2-a]azepine (1:1)
Formula:C16H12O4·C9H16N2
InChI:InChI=1S/C16H12O4.C9H16N2/c1-9(16(18)19)10-6-7-14-12(8-10)15(17)11-4-2-3-5-13(11)20-14;1-2-5-9-10-6-4-8-11(9)7-3-1/h2-9H,1H3,(H,18,19);1-8H2
InChI key:InChIKey=ZLFMLTKPDRGWFB-UHFFFAOYSA-N
SMILES:O=C(O)C(C1=CC=C2OC=3C=CC=CC3C(=O)C2=C1)C.N1=C2N(CCC1)CCCCC2
- Synonyms:
- 2-(9-Oxoxanthen-2-yl)propionic acid 1,8-diazabicyclo[5.4.0]undec-7-ene salt
- 9H-Xanthene-2-acetic acid, α-methyl-9-oxo-, compd. with 2,3,4,6,7,8,9,10-octahydropyrimido[1,2-a]azepine (1:1)
- α-Methylxanthoneacetic acid 1,8-diazabicyclo[5.4.0]undec-7-ene salt
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
2-(9-Oxoxanthen-2-yl)propionic Acid 1,8-Diazabicyclo[5.4.0]undec-7-ene Salt REF: 3B-O0448CAS: 1346753-05-6 | >98.0%(HPLC) | 322.00 € | Thu 02 Jan 25 | |
2-(9-Oxoxanthen-2-yl)propionic Acid 1,8-Diazabicyclo[5.4.0]undec-7-ene Salt REF: 3D-WDC75305CAS: 1346753-05-6 | Min. 95% | - - - | Discontinued product |
2-(9-Oxoxanthen-2-yl)propionic Acid 1,8-Diazabicyclo[5.4.0]undec-7-ene Salt
CAS:1346753-05-6
Formula:
C25H28N2O4
Purity:
>98.0%(HPLC)
Color and Shape:
White to Almost white powder to crystal
Molecular weight:
420.51
- Polymers
- Polymerization Initiators
- 6-membered Heterocycles
- Pyrans
- See more categories
- Biomaterials
Ref: 3B-O0448
1g | 322.00 € |
Estimated delivery in United States, on Thursday 2 Jan 2025
2-(9-Oxoxanthen-2-yl)propionic Acid 1,8-Diazabicyclo[5.4.0]undec-7-ene Salt
CAS:1346753-05-6
Please enquire for more information about 2-(9-Oxoxanthen-2-yl)propionic Acid 1,8-Diazabicyclo[5.4.0]undec-7-ene Salt including the price, delivery time …
Formula:
C25H28N2O4
Purity:
Min. 95%
Molecular weight:
420.51 g/mol
Ref: 3D-WDC75305
1g | Discontinued | Request information | |
5g | Discontinued | Request information | |
100mg | Discontinued | Request information | |
250mg | Discontinued | Request information | |
500mg | Discontinued | Request information |